Travis Dockter

1.5k total citations
43 papers, 860 citations indexed

About

Travis Dockter is a scholar working on Oncology, Dermatology and Pathology and Forensic Medicine. According to data from OpenAlex, Travis Dockter has authored 43 papers receiving a total of 860 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Oncology, 10 papers in Dermatology and 7 papers in Pathology and Forensic Medicine. Recurrent topics in Travis Dockter's work include Cancer Treatment and Pharmacology (16 papers), Chemotherapy-related skin toxicity (10 papers) and Lymphoma Diagnosis and Treatment (7 papers). Travis Dockter is often cited by papers focused on Cancer Treatment and Pharmacology (16 papers), Chemotherapy-related skin toxicity (10 papers) and Lymphoma Diagnosis and Treatment (7 papers). Travis Dockter collaborates with scholars based in United States and Australia. Travis Dockter's co-authors include Charles L. Loprinzi, Gerardo Colón‐Otero, Edith A. Perez, Pooja Advani, Karla V. Ballman, Jacqueline M. Lafky, Mario E. Lacouture, Kathryn J. Ruddy, Jennifer Le‐Rademacher and Shelby A. Terstriep and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer.

In The Last Decade

Travis Dockter

39 papers receiving 840 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Travis Dockter United States	14	560	160	129	116	103	43	860
Hege Sagstuen Haugnes Norway	22	578 1.0×	455 2.8×	178 1.4×	123 1.1×	108 1.0×	82	2.1k
Elizabeth Charlotte Moser Portugal	15	280 0.5×	144 0.9×	80 0.6×	147 1.3×	34 0.3×	39	792
Polly Niravath United States	14	456 0.8×	209 1.3×	27 0.2×	69 0.6×	120 1.2×	53	970
Farzin Khosrow‐Khavar Canada	11	248 0.4×	171 1.1×	171 1.3×	44 0.4×	23 0.2×	37	730
Christophe Leux France	24	480 0.9×	340 2.1×	34 0.3×	275 2.4×	271 2.6×	57	1.7k
Rümeysa Çiftçi Türkiye	16	385 0.7×	249 1.6×	136 1.1×	79 0.7×	24 0.2×	43	776
Paula Silverman United States	21	901 1.6×	306 1.9×	74 0.6×	125 1.1×	38 0.4×	60	1.6k
Gülten Tekuzman Türkiye	15	334 0.6×	171 1.1×	234 1.8×	143 1.2×	22 0.2×	58	737
Tobias Höller Germany	22	319 0.6×	154 1.0×	49 0.4×	118 1.0×	16 0.2×	39	1.2k
M. Beauduin Belgium	18	662 1.2×	330 2.1×	118 0.9×	90 0.8×	30 0.3×	70	1.2k

Countries citing papers authored by Travis Dockter

Since Specialization

Citations

This map shows the geographic impact of Travis Dockter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Travis Dockter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Travis Dockter more than expected).

Fields of papers citing papers by Travis Dockter

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Travis Dockter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Travis Dockter. The network helps show where Travis Dockter may publish in the future.

Co-authorship network of co-authors of Travis Dockter

This figure shows the co-authorship network connecting the top 25 collaborators of Travis Dockter. A scholar is included among the top collaborators of Travis Dockter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Travis Dockter. Travis Dockter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Boughey, Judy C., Vera J. Suman, Kelly J. Hunt, et al.. (2025). Abstract RF2-01: Factors Influencing Additional Nodal Disease and Pathologic Nodal Upstaging with Axillary Dissection in Patients with Residual Node-Positive Breast Cancer After Neoadjuvant Chemotherapy Enrolled on Alliance A011202 Clinical Trial. Clinical Cancer Research. 31(12_Supplement). RF2–1. 3 indexed citations

Beaven, Anne, Susan M. Geyer, Jonathon B. Cohen, et al.. (2024). Trial in Progress - Alliance A052101: A Randomized Phase 3 Trial of Continuous Vs. Intermittent Maintenance Therapy with Zanubrutinib As Upfront Treatment in Older Patients with Mantle Cell Lymphoma. Blood. 144(Supplement 1). 1661.3–1661.3.

Wood, Christina, et al.. (2024). Music Therapy Intervention to Reduce Symptom Burden in Hospice Patients: A Descriptive Study. American Journal of Hospice and Palliative Medicine®. 42(1). 102–111. 2 indexed citations

Chang, George J., Lisa M. Lowenstein, Daniel Dohan, et al.. (2024). Improving Surgical Care and Outcomes in Older Cancer Patients Through Implementation of a Presurgical Toolkit (OPTI-Surg)—Final Results of a Phase III Cluster Randomized Trial (Alliance A231601CD). Annals of Surgery. 280(4). 623–632. 2 indexed citations

Phelps, Christina, et al.. (2023). Music Therapy Intervention to Reduce Caregiver Distress at End of Life: A Feasibility Study. Journal of Pain and Symptom Management. 65(5). e417–e423. 6 indexed citations

Chang, George J., Lisa M. Lowenstein, Daniel Dohan, et al.. (2023). Surgical care and outcomes in older patients with cancer through implementation of a pre-surgical toolkit (OPTI-Surg): Interim results of a phase III cluster randomized trial (Alliance A231601CD).. Journal of Clinical Oncology. 41(16_suppl). 1541–1541. 1 indexed citations

LaCasce, Ann S., Travis Dockter, Amy S. Ruppert, et al.. (2022). Positron Emission Tomography–Adapted Therapy in Bulky Stage I/II Classic Hodgkin Lymphoma: CALGB 50801 (Alliance). Journal of Clinical Oncology. 41(5). 1023–1034. 16 indexed citations

Zahrieh, David, Shauna L. Hillman, Angelina D. Tan, et al.. (2022). Successes and lessons learned in database development for national multi-site cancer care delivery research trials: the Alliance for Clinical Trials in Oncology experience. Trials. 23(1). 645–645. 2 indexed citations

Albany, Costantine, Travis Dockter, Eric Wolfe, et al.. (2021). Correction to: Cisplatin-associated neuropathy characteristics compared with those associated with other neurotoxic chemotherapy agents (Alliance A151724). Supportive Care in Cancer. 29(11). 7129–7130. 1 indexed citations

10.

VanderWalde, Noam A., Travis Dockter, Daniel V. Wakefield, et al.. (2021). Disparities in older adult accrual to cancer trials: Analysis from the alliance for clinical trials in oncology (A151736). Journal of Geriatric Oncology. 13(1). 20–26. 12 indexed citations

11.

Hertz, Daniel L., Travis Dockter, Daniel Satele, Charles L. Loprinzi, & Jennifer Le‐Rademacher. (2021). Neuropathy severity at the time of oxaliplatin treatment alteration in patients with colon cancer (Alliance A151912). Supportive Care in Cancer. 29(12). 7855–7863. 6 indexed citations

12.

Cynthia, X., Vera J. Suman, A. Marilyn Leitch, et al.. (2020). ALTERNATE: Neoadjuvant endocrine treatment (NET) approaches for clinical stage II or III estrogen receptor-positive HER2-negative breast cancer (ER+ HER2- BC) in postmenopausal (PM) women: Alliance A011106.. Journal of Clinical Oncology. 38(15_suppl). 504–504. 27 indexed citations

13.

Quick, Allison, Travis Dockter, Jennifer Le‐Rademacher, et al.. (2020). Pilot study of fractional CO2 laser therapy for genitourinary syndrome of menopause in gynecologic cancer survivors. Maturitas. 144. 37–44. 35 indexed citations

14.

Ruddy, Kathryn J., Jennifer Le‐Rademacher, Mario E. Lacouture, et al.. (2019). Randomized controlled trial of cryotherapy to prevent paclitaxel-induced peripheral neuropathy (RU221511I); an ACCRU trial. The Breast. 48. 89–97. 38 indexed citations

15.

Bekaii‐Saab, Tanios, Fang‐Shu Ou, Daniel H. Ahn, et al.. (2019). Regorafenib dose-optimisation in patients with refractory metastatic colorectal cancer (ReDOS): a randomised, multicentre, open-label, phase 2 study. The Lancet Oncology. 20(8). 1070–1082. 181 indexed citations

16.

Barton, Debra L., Jeff A. Sloan, Lynne T. Shuster, et al.. (2017). Evaluating the efficacy of vaginal dehydroepiandosterone for vaginal symptoms in postmenopausal cancer survivors: NCCTG N10C1 (Alliance). Supportive Care in Cancer. 26(2). 643–650. 54 indexed citations

17.

Karnatovskaia, Lioudmila V., Margaret M. Johnson, Travis Dockter, & Ognjen Gajic. (2016). Perspectives of physicians and nurses on identifying and treating psychological distress of the critically ill. Journal of Critical Care. 37. 106–111. 6 indexed citations

18.

Jatoi, Aminah, Travis Dockter, Matthew S. Block, et al.. (2016). A proof-of-concept trial of protein kinase C iota inhibition with auranofin for the paclitaxel-induced acute pain syndrome. Supportive Care in Cancer. 25(3). 833–838. 9 indexed citations

19.

Advani, Pooja, Karla V. Ballman, Travis Dockter, Gerardo Colón‐Otero, & Edith A. Perez. (2015). Long-Term Cardiac Safety Analysis of NCCTG N9831 (Alliance) Adjuvant Trastuzumab Trial. Journal of Clinical Oncology. 34(6). 581–587. 115 indexed citations

20.

Leal, Alexis D., Rui Qin, Pamela J. Atherton, et al.. (2014). North Central Cancer Treatment Group/Alliance trial N08CA—the use of glutathione for prevention of paclitaxel/carboplatin‐induced peripheral neuropathy: A phase 3 randomized, double‐blind, placebo‐controlled study. Cancer. 120(12). 1890–1897. 63 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact